REGISTRO EUROPEO SOBRE INSUFICIENCIA CARDÍACA A LARGO PLAZO.

Article. 10.1007/s40292-021-00476-4. 2021

Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1097/TP.0000000000004273. 2022

Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.09.003. 2021

Analysis of complications in patients with ECMO as a bridge to transplantation since the beginning of the technique (2007-2023)

Guerrero Cervera, Borja; (...); Almenar Bonet, Luis

Meeting Abstract. 2024

Analysis of Heart Transplant Survival According to Difference in Age Between Donor and Recipient.

Article. 10.1016/j.transproceed.2022.10.014. 2022

Analysis of heart transplantation survival according to difference in age between donor and recipient

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Analysis of hospital mortality and primary graft dysfunction in urgent heart transplantation according to the type and duration of circulatory/ventricular assistance

Meeting Abstract. 2017

Analysis of the implantation of heart failure with reduced ejection fraction treatment in clinical practice and its impact on achieving target doses

Esteban Fernandez, A. Alberto; (...); Fernandez, V. Alonso

Meeting Abstract. 2023

Analysis of the Intrahospital and Long-Term Survival of Heart Transplant Patients With a Short-Term Mechanical Assistance Device.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.transproceed.2021.06.030. 2021

Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.

Article. 10.1186/s12872-024-03728-y. 2024

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

Sánchez-Lázaro I; (...); Aliño SF

Article. 10.2217/pgs.15.39. 2015

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project

Pose, A; (...); Manito, N

Article. 10.1002/ehf2.12124. 2017

beta(2)- and beta(1)-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases

Montó F; (...); D'Ocon P

Article. 10.1097/FJC.0000000000000299. 2015

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Barge Caballero, E. Eduardo; (...); Crespo-Leiro, M.

Meeting Abstract. 2022

Can the number of Comorbidities predict readmissions for Heart Failure patients?

Ferre, MFM; (...); Almenar, L

Meeting Abstract. 2018

Can we start quadruple therapy in new-diagnosed heart failure patients in real life? Insights into the basal characteristics of TIDY-HF register

Esteban Fernandez, A.; (...); Torres Lego, J.

Meeting Abstract. 2022

Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History

Delgado, JF; (...); Crespo-Leiro, MG

Article. 10.1111/ajt.13637. 2016

Carbohydrate antigen 125 and glutamic oxaloacetic transaminase as congestion markers in acute heart failure. Is there clinical association between them?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.3390/jpm12060913. 2022

Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.

Roselló-Lletí E; (...); Rivera M

Article. 10.1111/j.1582-4934.2012.01565.x. 2012

Cardiac S1P/Ceramide imbalance in human heart failure: implication of gene dysregulation

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.

Alania-Torres, Edgardo; (...); Valle-Munoz, Alfonso

Case Reports. 10.3389/fcvm.2021.759119. 2021

CCSER2 and RAC3 serum expression levels detect cardiac allograft rejection

Rodriguez, J. M.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Circulating biomarkers for the detection of the pre-capillary component in patients with pulmonary hypertension due to left heart diseases

Ferrer, JLM; (...); Bonet, LA

Meeting Abstract. 2017

Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection.

Pérez-Carrillo L; (...); Roselló-Lletí E

Letter. 10.1186/s40364-024-00590-0. 2024

Clinical outcomes of temporary mechanical circulatory support as a bridge to heart transplantation in Spain: a nationwide registry.

Caballero, EEB; (...); Mirabet-Perez, S

Meeting Abstract. 2017

Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry

Barge-Caballero, E; (...); Crespo-Leiro, MG

Article. 10.1002/ejhf.956. 2018

Clinical phenotypes according to diuretic combination in acute heart failure.

Article. 10.1016/j.hjc.2023.03.009. 2023

Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.

Article. 10.3389/fcvm.2024.1381514. 2024

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry.

Alonso Salinas, Gonzalo Luis; (...); Diez-Villanueva, Pablo

Article. 10.1002/ehf2.15260. 2025

Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Cold ischemia >4 hours increases heart transplantation mortality. An analysis of the Spanish heart transplantation registry

Valero-Masa, MJ; (...); Martinez-Selles, M

Article. 10.1016/j.ijcard.2020.06.009. 2020

Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients.

Pérez-Carrillo L; (...); Roselló-Lletí E

Article. 10.1097/TP.0000000000004622. 2023

Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients

Perez-Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022

Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.

Anguita M; (...); Vazquez de Prada JA

Editorial Material. 10.1016/j.recesp.2012.07.013. 2012

COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Article. 10.3390/biomedicines12092109. 2024

Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.08.040. 2021

Comprehensive survival analysis in acute heart failure: profiling patients through clinical examination at admission

Raquel Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Consensus on the management of hyperkalemia in patients with heart failure: recommendations from the SEC-SEMI

Bonet, L. Almenar, Gonzalez-Franco, A.

Article. 10.1016/j.rce.2020.11.009. 2022

Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI.

Almenar Bonet, L, Gonzalez-Franco, A

Article. 10.1016/j.rceng.2020.11.012. 2021

Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study

Gonzalez-Vilchez, F; (...); Crespo-Leiro, MG

Article. 10.1016/j.transproceed.2019.04.028. 2019

Correlates of musculoskeletal pain and kinesiophobia in older adults with heart failure: A structural equation model.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1016/j.gerinurse.2023.07.003. 2023

Correlation of various molecules involved in cellular traffic with the severity of heart failure in patients undergoing cardiac transplantation

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018

Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain.

Almenar L; (...); Daubert C

Article. 10.1017/S0266462313000123. 2013

COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital.

Article. 10.1016/j.transproceed.2021.07.054. 2021

COVID-19 infection in heart transplants in pre- and post-vaccination periods

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.005. 2022

Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.

Article. 10.1080/00015385.2020.1871264. 2021

Cross-sectional study of cardiac resynchronization therapy in Spain. Indications, implant techniques, optimization and follow-up.

Hernández-Madrid A; (...); Fernández Lozano I

Article. 10.1016/j.recesp.2012.03.019. 2012

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Article. 2022

Current situation of management of systolic heart failure in Spain: VIDA-IC study results.

Anguita M; (...); Investigators of the VIDA–IC Study

Letter. 10.1016/j.rec.2014.03.014. 2014

CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN

Meeting Abstract. 2021

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON)

Beltran, IIC; (...); Nunez, J

Meeting Abstract. 2018

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design

Minana, G; (...); Myocardial-IRON Investigators

Article. 10.1002/clc.22956. 2018

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study

Escribano-Subias, P; (...); Barbera, JA

Article. 10.1186/s12890-020-01197-5. 2020

Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge.

Article. 10.1016/j.transproceed.2022.10.002. 2022

Changes over the years in the indication for heart-lung transplantation in Spain

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Chronic Renal Dysfunction in Maintenance Heart Transplant Patients: The ICEBERG Study

González-Vílchez F; (...); Guinea G

Article. 10.1016/j.transproceed.2013.09.031. 2014

Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation

Carbone, J; (...); Sarmiento, E

Meeting Abstract. 10.1016/j.healun.2018.01.379. 2018

Depression mediates physical activity readiness and physical activity in patients with heart failure

Deka, Pallav; (...); Marques-Sule, Elena

Article. 10.1002/ehf2.13609. 2021

Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries

Dobarro, David; (...); Gonzalez-Costello, Jose

Article. 10.3390/life14121570. 2024

Diagnostic power of echocardiographic speckle tracking of the tricuspid annular motion to assess right ventricular dysfunction

Alonso P; (...); Salvador A

Letter. 10.1016/j.ijcard.2013.12.157. 2014

Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1016/j.healun.2021.10.004. 2022

Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables.

Montó F; (...); D'Ocon P

Article. 10.1152/ajpheart.01061.2011. 2012

Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure

Tarazón E; (...); Portolés M

Letter. 10.1016/j.ijcard.2014.04.037. 2014

Does the age of the recipient influence the survival of the heart transplant?

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation?

Rodríguez-Serrano M; (...); Salvador-Sanz A

Article. 10.1111/ctr.12282. 2014

Does the Calcineurin Inhibitor Have Influence on Cytomegalovirus Infection in Heart Transplantation?

Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.

Article. 10.1016/j.healun.2014.01.067. 2014

Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry

Martinez-Selles M; (...); Spanish Registry of Heart Transplantation

Article. 10.1111/tri.12488. 2015

Donor-Transmitted Coronary Artery Disease in Heart Transplantation: Prevalence and Characteristics in the Real World. Results from the Multicentric Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2022

Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry.

Gomez-Bueno, Manuel; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2022.07.011. 2022

Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study.

Sánchez-González JL; (...); Marques-Sule E

Article. 10.3390/jcm12227090. 2023

Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.

Gonzalez-Vilchez, F; (...); de Prada, JAV

Article. 10.1016/j.rec.2017.03.014. 2018

Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial

Comin-Colet, J; (...); LION-HEART Study Investigators

Article. 10.1002/ejhf.1145. 2018

EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL?

Meeting Abstract. 2021

Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

Article. 10.3389/ti.2022.10197. 2022

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

McMurray JJ; (...); ESC Committee for Practice Guidelines

Article. 10.1093/eurjhf/hfs105. 2012

Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

Sarmiento, E; (...); Carbone, J

Article. 10.1016/j.healun.2016.10.004. 2017

Evaluation of the preoperative vasoactive-inotropic score as a predictor of postoperative outcomes in patients undergoing heart transplantation

Barge-Caballero E; (...); Crespo-Leiro M

Letter. 10.1016/j.ijcard.2015.03.098. 2015

Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.006. 2022

Evolving Indications for Heart-Lung Transplant in Spain.

Article. 10.1016/j.transproceed.2022.10.003. 2022

Experience with COVID-19 heart transplant patients in a tertiary hospital

Donoso, V.; (...); Almenar Bonet, L.

Article. 2021

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

Esteban-Fernandez, Alberto; (...); Lopez-Vilella, Raquel

Article. 10.1002/ehf2.13976. 2022

Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.

Klompstra L; (...); Marques-Sule E

Article. 10.1093/eurjcn/zvae144. 2024

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study

Garay, A; (...); VIDA-IC Multicenter Study Investig

Article. 10.3390/jcm9092825. 2020

Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy

Herrer I; (...); Rivera M

Article. 10.1186/s12920-015-0088-y. 2015

Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

Bosó V; (...); Aliño SF

Article. 10.1097/FTD.0b013e3182a94e65. 2014

Golgi ribbon integrity in human patients with chronic heart failure

Gimenez Escamilla, I.; (...); Tarazon, E.

Meeting Abstract. 2021

Health-related Quality of Life of Patients With Chronic Systolic Heart Failure in Spain: Results of the VIDA-IC Study.

Comin-Colet, J; (...); VIDA-IC Quality Life Heart Failure

Article. 10.1016/j.rec.2015.07.030. 2016

Health-related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross-sectional study

Delgado JF; (...); Crespo-Leiro MG

Article. 10.1111/ctr.12578. 2015

Heart Failure Induces Significant Changes in Nuclear Pore Complex of Human Cardiomyocytes

Tarazon, Estefania; (...); Portoles, Manuel

Article. 2012

Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital

Donoso, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

Heart transplantation and metabolic syndrome: which calcineurin inhibitor most promotes its development?

Martinez-Dolz, L.; (...); Salvador-Sanz, A.

Article. 2013

Heart transplantation using allografts from older donors: Multicenter study results

Roig E; (...); Muñiz J

Article. 10.1016/j.healun.2014.10.006. 2015

How much does right ventricular dysfunction influence the elevation of NT-proBNP in patients with acute heart failure?

Meeting Abstract. 2018

Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry.

Crespo-Leiro, Maria G.; (...); Delgado-Jimenez, Juan

Article. 10.1016/j.recesp.2019.05.004. 2020

Hyperkalemia in heart failure patients: current challenges and future prospects

Review. 10.2147/RRCC.S75680. 2016

Hypertonic saline solution with furosemide for the treatment of congestive symptoms of acute heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan

Pose, A; (...); Manito, N

Article. 10.1016/j.rce.2017.02.013. 2017

Idarucizumab in High-risk Thoracic Surgery

Article. 2018

Identification of sarcomere serum biomarkers for non-invasive diagnosis of cardiac rejection

Perez Carrillo, L.; (...); Esther Rosello-Lleti, E.

Meeting Abstract. 2021

Impact of basal heart rate on long-term prognosis of heart transplant patients.

Melero-Ferrer JL; (...); Salvador-Sanz A

Article. 10.1111/tri.12082. 2013

Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

Martinez-Lauwers, Ana; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.08.041. 2021

Impact of circulatory assistance in the early evolution after heart transplantation: unicentric experience.

Martinez-Lauwers, A.; (...); Martinez-Dolz, L.

Meeting Abstract. 2020

Impact of comorbidities in outpatients with chronic heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

Article. 10.1016/j.recesp.2020.02.018. 2020

Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes.

González-Vílchez F; (...); Vázquez de Prada JA

Article. 10.1016/j.rec.2021.02.001. 2021

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.

Article. 10.1002/ehf2.13753. 2022

Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO.

Enríquez-Vázquez D; (...); Crespo-Leiro MG

Article. 10.1016/j.rec.2024.09.005. 2024

Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation

Enriquez Vazquez, D.; (...); Crespo-Leiro, M.

Meeting Abstract. 2024

Impact of serum levels variability of calcineurin inhibitors on heart transplant outcomes

Gonzalez-Vilchez, FJFJ; (...); De Prada, JAV

Meeting Abstract. 2019

Impact of short-termmechanical circulatory support with extracorporeal devices on postoperative outcomes after emergency heart transplantation: Data from a multi-institutional Spanish cohort

Barge-Caballero E; (...); Crespo-Leiro M

Article. 10.1016/j.ijcard.2014.06.036. 2014

Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.

Donoso-Trenado, Victor; (...); Almenar-bonet, Luis

Article. 10.1016/j.transproceed.2024.12.005. 2024

Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.

Perez-Carrillo, Lorena; (...); Tarazon, Estefania

Article. 10.3390/biomedicines10010135. 2022

Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.14630. 2023

Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial

Cleland, JGF; (...); Pitt, B

Meeting Abstract. 2019

Incidence and factors related to vasoplegia in the early postoperatory period of orthotopic heart transplantation

Meeting Abstract. 2018

Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry

Sagastagoitia-Fornie, Marta; (...); Crespo-Leiro, Maria G.

Article. 10.3389/ti.2023.11042. 2023

Incidence and prognostic impact of adverse clinical events associated to mechanical circulatory support in patients bridged to transplantation on temporary devices: a nationwide Spanish registry.

Caballero, EEB; (...); Hervas-Sotomayor, D

Meeting Abstract. 2017

Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor

López-Vilella R; (...); Montero-Argudo A

Article. 10.1016/j.transproceed.2014.11.025. 2015

Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor (vol 47, pg 127, 2015)

Lopez-Vilella, R.; (...); Montero-Argudo, A.

Article. 10.1016/j.transproceed.2015.09.023. 2015

Indirect effects of cytomegalovirus infection and the utility of utility of valganciclovir

Martinez-Dolz, L.; (...); Almenar-Bonet, L.

Article. 2014

Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates.

Solla-Buceta M; (...); Barge-Caballero E

Article. 10.1016/j.rec.2020.11.019. 2021

Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.

Esteban-Fernández A; (...); Ridocci-Soriano F

Article. 10.1007/s00392-023-02241-0. 2024

Influence of the type of circulatory/ventricular assistance in the primary graft failure and heart transplantation mortality

Meeting Abstract. 2018

Influence on kinesiophobia by disability, physical, and behavioural variables after a heart transplantation.

Marques-Sule E; (...); Bäck M

Article. 10.1093/eurjcn/zvab134. 2022

Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center

Martin, PA; (...); Bonet, LA

Meeting Abstract. 2018

Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant.

Bonet LA; (...); Sanz AS

Article. 10.5301/HEART.2014.12492. 2014

Iron deficiency and short-term adverse events in patients with decompensated heart failure.

Palau P; (...); Núñez J

Article. 10.1007/s00392-021-01832-z. 2021

Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?

Lopez-Vilella, Raquel; (...); Almenar Bonet L

Article. 10.3390/life13040915. 2023

Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?

Lopez Vilella, R. Raquel; (...); Bonet, L. Almenar

Meeting Abstract. 2023

Is there a variation of CA-125 levels with changes in glomerular filtration rate in patients with heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Is there changes in the diuretic response to hypertonic saline plus furosemide depending on the type of heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Kinesiophobia and associated variables in patients with heart failure.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1093/eurjcn/zvad072. 2023

Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences

Moreno Segura, N.; (...); Marques-Sule, E.

Meeting Abstract. 2023

Kinesiophobia, physical activity and quality of life in patients with heart failure: a cross-sectional study

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Long-term changes in left ventricular ejection fraction depending on the type of heart failure

Meeting Abstract. 2018

Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Malignancy after Heart Transplantation: Difference in incidence and prognosis between genders. Data from the Spanish post-Heart Transplant Tumor Registry

Minguito Carazo, C.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2019

Malignancy following Heart Transplantation: Differences in Incidence and Prognosis between Sexes.

Minguito-Carazo C; (...); Crespo-Leiro MG

Article. 10.1111/tri.13827. 2021

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

Aguado, JM; (...); Spanish Network for Research in Infectious Diseases (REIPI) (RD16

Article. 10.1016/j.trre.2017.07.001. 2018

Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation.

Olivella, Aleix; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.healun.2023.03.008. 2023

Metabolic syndrome in heart transplantation: impact on survival and renal function.

Martínez-Dolz L; (...); Montero JA

Article. 10.1111/tri.12149. 2013

Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.

Ezzitouny, M.; (...); Martinez-Dolz, L.

Article. 10.1016/j.transproceed.2018.12.013. 2019

Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.

Article. 10.1016/j.amjcard.2023.03.008. 2023

Musculoskeletal disorders in men and women with heart transplantation. A cross-sectional study

Segura, N. Moreno; (...); Marques-Sule, E.

Meeting Abstract. 2023

Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.

Vicente D; (...); D'Ocon P

Article. 10.1016/j.lfs.2013.05.025. 2013

National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Society Española Internal Medicine (SEMI). Spanish Society of Thrombosis and Haemostasis (SETH). Spanish Society of Cardiology (ESC). Spanish Society of Medicine Accident and Emergency (SEMES). Spanish Society of Angiology and Surgery Vascular (SEACV).

Uresandi F; (...); Society Española Internal Medicine (SEMI)

Article. 10.1016/j.arbres.2013.07.008. 2013

New concepts and best practices for management of pre- and post-transplantation cancer.

Campistol JM; (...); Ussetti P

Article. 10.1016/j.trre.2012.07.001. 2012

No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study

Cassado-Valls, Paula; (...); Comin-Colet, Josep

Article. 10.3390/jcm13247558. 2024

Non-invasive diagnosis of cardiac rejection using small non-coding RNAs

Gimenez-Escamilla, I.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.

Núñez J; (...); Bayés-Genís A

Article. 10.1161/JAHA.119.014254. 2020

Novel Imaging Techniques for Heart Failure.

Melero-Ferrer JL; (...); Martinez-Dolz L

Article. 10.15420/cfr.2015:29:2. 2016

Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy

Esteban Fernandez, A. Alberto; (...); De Juan Baguda, J.

Meeting Abstract. 2024

Percutaneous biventricular mechanical assistance as a bridge to heart transplant.

Perez-Guillen, Manuel; (...); Martinez-Leon, Juan B

Case Reports. 10.1016/j.rec.2023.07.007. 2023

Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience

Letter. 10.1016/j.recesp.2022.04.017. 2023

Phenotypic patterns of right ventricular dysfunction: analysis by cardiac magnetic imaging.

J Sánchez-Lázaro I; (...); Salvador-Sanz A

Article. 10.4081/hi.2013.e3. 2013

Physical activity enjoyment, exercise motivation, and physical activity in patients with heart failure: A mediation analysis.

Klompstra L; (...); Marques-Sule E

Article. 10.1177/02692155221103696. 2022

Physical activity readiness in patients with heart failure

Klompstra, L; (...); Almenar, L

Meeting Abstract. 2020

Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Lozano-Edo S; (...); Martínez-Dolz L

Article. 10.1097/TP.0000000000003798. 2021

Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.

Romero S; (...); Sanz J

Article. 10.1080/10428194.2018.1474462. 2019

Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.

Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C

Article. 10.1111/ctr.70027. 2025

Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry.

Barge-Caballero E; (...); Crespo-Leiro M

Article. 10.1161/CIRCHEARTFAILURE.112.000237. 2013

Preoperative Toxoplasma gondii serostatus does not affect long-term survival of cardiac transplant recipients. Analysis of the Spanish Heart Transplantation Registry

Barge-Caballero, E; (...); Gonzalez-Vilchez, F

Article. 10.1016/j.ijcard.2017.09.215. 2018

Presence and evolution of multiple pulmonary nodules with halo sign detected by computerized tomography in advanced heart failure

Meeting Abstract. 2018

Prevalence of fragmented QRS complex and factors related with its occurrence

Martinez-Dolz, L.; (...); Almenar-Bonet, L.

Article. 2014

Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study

Helmy, R; (...); BRIGHT Study Team

Article. 10.1016/j.clinthera.2018.11.007. 2019

Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.

Article. 10.1016/j.transproceed.2022.09.009. 2022

Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction

Otero Garcia, O.; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 2024

Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients.

Couto-Mallón D; (...); Crespo-Leiro MG

Article. 10.1016/j.jacc.2023.06.016. 2023

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics.

Delgado-Jimenez, Juan F.; (...); Crespo-Leiro, Maria G.

Article. 10.3390/jcm11051170. 2022

Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score.

Cosío Carmena MD; (...); Segovia J

Article. 10.1016/j.healun.2013.08.004. 2013

Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis.

Urbistondo, Francisco Gonzalez; (...); De Prada, Jose Antonio Vazquez

Article. 10.1016/j.rec.2023.10.006. 2023

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry

Vega, D. Garcia; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.1187. 2024

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry

Garcia Vega, D. David; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.1187. 2024

Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.

Laymito-Quispe RDP; (...); Almenar-Bonet, Luis

Article. 10.1016/j.medcli.2021.03.037. 2022

Prognostic Value of Serum Lactate Levels in Patients Undergoing Urgent Heart Transplant: A Subanalysis of the ASIS-TC Spanish Multicenter Study

Couto-Mallon, D; (...); Barge-Caballero, E

Article. 10.1016/j.rec.2018.02.021. 2019

Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency.

Zuckermann A; (...); Kushwaha S

Article. 10.1111/j.1600-6143.2012.04131.x. 2012

Real world comparison of spironolactone and eplerenone in patients with heart failure.

Pardo-Martinez, Patricia; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.ejim.2021.12.027. 2022

Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.

González-Vílchez F; (...); Farrero M

Article. 10.1111/ctr.12241. 2013

Repetitive ambulatory doses of levosimendan as a bridge to heart transplant: patients characteristics and prescription patterns from the LEVO-T Registry.

De Juan Baguda, J.; (...); Gonzalez Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory levosimendan as a bridge to heart transplantation.

Baguda, Javier De Juan; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2023.07.002. 2023

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.recesp.2021.06.010. 2022

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry.

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.rec.2021.06.009. 2021

Revascularization of Donor Transmitted Coronary Artery Disease After Heart Transplantation: Impact on Survival and Cardiovascular Events. Insights from the DONOR-CAD Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation

Vilella, RL; (...); Bonet, LA

Meeting Abstract. 2018

Review of the allocation criteria for heart transplant in Spain in 2023 . SEC-Heart Failure Association/ONT/SECCE consensus document

González-Costello J; (...); Domínguez-Gil B

Review. 10.1016/j.rec.2023.11.001. 2024

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Spyropoulos, AC; (...); MARINER Investigators

Article. 10.1056/NEJMoa1805090. 2018

RNA Sequencing Analysis Identifies New Human Collagen Genes Involved in Cardiac Remodeling

Gil-Cayuela C; (...); Portolés M

Letter. 10.1016/j.jacc.2015.01.029. 2015

Role of DNMT3B system in human ischemic hearts

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode.

Olivella, Aleix; (...); Facila Rubio, Lorenzo

Article. 10.1002/ehf2.14647. 2023

Sarcomere ACTC1 and MYO18A serum expression levels detect acute cellular rejection in cardiac transplant patients

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry

Ambrosio, Giuseppe; (...); Maggioni, Aldo P.

Article. 10.1016/j.ejim.2021.04.001. 2021

Sex, Temporary Mechanical Circulatory Support, and HeartTransplantation: Insights From a Multi-Institutional SpanishRegistry.

Enriquez-Vazquez, Daniel; (...); Crespo-Leiro, Maria G.

Letter. 10.1016/j.jchf.2023.07.027. 2023

Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.13053. 2020

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.

Del Canto I; (...); Núñez J

Article. 10.1161/JAHA.121.022214. 2022

Short-term changes in left and right ventricular CMR feature tracking strain following ferric carboxymaltose in patients with heart failure: a substudy of the Myocardial-IRON trial

Del Canto Serrano, I.; (...); Nunez, J. V.

Meeting Abstract. 2021

Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation

Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.

Article. 10.1016/j.healun.2014.01.392. 2014

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Otero Garcia, O. Oscar; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.836. 2024

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.836. 2024

Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.

Article. 10.1016/j.ejim.2022.06.008. 2022

Spanish Heart Transplant Registry. 28th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2016)

Gonzalez-Vilchez, F; (...); Spanish Heart Transplant Teams

Article. 10.1016/j.recesp.2017.07.032. 2017

Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure

Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T

Article. 10.1016/j.recesp.2018.07.020. 2018

Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)

Gonzalez-Vilchez, F; (...); Abella-Anton, R

Article. 10.1016/j.rec.2019.09.005. 2019

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, F; (...); Casasnovas, IS

Article. 10.1016/j.recesp.2020.06.024. 2020

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vilchez F; (...); Groba Marco MDV

Article. 10.1016/j.rec.2020.06.035. 2020

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, Francisco; (...); Jesus Valero-Masa, Maria

Article. 10.1016/j.recesp.2021.06.012. 2021

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

Gonzalez-Vilchez, Francisco; (...); Valero-Masa, Maria Jesus

Article. 10.1016/j.rec.2021.08.001. 2021

Spanish heart transplant registry. 33rd official report of the Heart failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2022.06.011. 2022

Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2023.06.013. 2023

Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2024.05.015. 2024

Spanish Heart Transplantation Registry. 24th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2012).

González-Vílchez F; (...); Spanish Heart Transplant Teams

Article. 10.1016/j.rec.2013.08.004. 2013

Spanish Heart Transplantation Registry. 25th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013).

González-Vílchez F; (...); Spanish Heart Transplantation Teams

Article. 10.1016/j.rec.2014.09.005. 2014

Spanish Heart Transplantation Registry. 26th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2014).

Gonzalez-Vilchez, F; (...); Spanish Heart Transplantation Team

Article. 10.1016/j.rec.2015.07.009. 2015

Spanish Heart Transplantation Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2015).

Gonzalez-Vilchez, F; (...); Spanish Heart Transplant Teams

Article. 10.1016/j.rec.2016.07.010. 2016

Spanish multicenter study on the monitoring and incidence of hyperkalaemia in patients with heart failure and reduced ejection fraction. SPANIK-HF

Crespo-Leiro, M.; (...); Delgado-Jimenez, J. F.

Meeting Abstract. 2022

Spanish registry on heart transplantation. 23rd official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2011).

Almenar L; (...); Spanish Heart Transplantation Teams

Article. 10.1016/j.recesp.2012.07.012. 2012

Specific test panels for patients with heart failure: implementation and use in the Spanish National Health System

Almenar Bonet, Luis; (...); Generosa Crespo-Leiro, Andmaria

Article. 10.1515/almed-2022-0006. 2022

Study of molecules involved in cellular traffic in advanced heart failure: are there differences in the nivels of these molecules between ischemic heart disease and idiopathic dilated cardiomyopathy?

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018

Study of Natriuretic Peptides Levels in the Left Ventricular Tissue of Patients With Dilated Cardiomyopathy Using RNA-Seq

Rosello Lleti, Esther; (...); Portoles Sanz, Manuel

Article. 2013

Technology usage, interest and preferences about technology-based cardiac rehabilitation programmes in heart failure

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Technology Usage, Physical Activity, and Motivation in Patients With Heart Failure and Heart Transplantation.

Deka P; (...); Marques-Sule E

Article. 10.1097/CIN.0000000000001049. 2023

Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study.

Barge-Caballero, Eduardo; (...); Crespo-Leiro, Maria G.

Article. 10.1016/j.healun.2022.10.020. 2022

The falling incidence of hematologic cancer after heart transplantation

Crespo-Leiro, MG; (...); Muniz, J

Article. 10.1111/ctr.12432. 2014

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.

Article. 10.3389/fcvm.2021.618398. 2021

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients

Roman A; (...); Ussetti P

Article. 10.1016/j.trre.2014.01.001. 2014

Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

Article. 10.1002/ehf2.14386. 2023

Three cases of psychosis after use of sacubitril/valsartan.

Perez-Rosello, Victor; (...); Almenar-Bonet, Luis

Letter. 10.1016/j.recesp.2020.05.019. 2021

Tolvaptan in hyponatremic patients with heart failure: initial experience

Martinez-Dolz, L.; (...); Salvador-Sanz, A.

Article. 2013

Toxoplasma gondii serostatus is not an independent predictor of survival in heart transplant recipients: analysis of the Spanish Heart Transplant Registry

Caballero, EEB; (...); Blasco-Peiro, T

Meeting Abstract. 2017

Transient pulmonary nodules with halo sign in patients with advanced heart failure: a report of two cases.

López-Vilella R; (...); Bonet LA

Article. 10.1016/j.clinimag.2019.11.008. 2020

Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry.

Paniagua Martín MJ; (...); Albert DC

Article. 10.1111/j.1399-0012.2012.01611.x. 2012

Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.

Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022

Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.835. 2024

Update on heart failure, heart transplant, congenital heart disease, and clinical cardiology.

Almenar L; (...); Díaz-Molina B

Article. 10.1016/j.rec.2012.10.018. 2013

Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.

Alonso P; (...); Montero A

Article. 2014

Use of a surgically implanted, extracorporeal continuous flow circulatory support system as a bridge to heart transplantation

Cabezon Villalba, G. Gonzalo; (...); Crespo-Leiro, M. G. C. L.

Meeting Abstract. 2023

Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant.

Villalba, Gonzalo Cabezon; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.rec.2023.05.002. 2024

Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain

Crespo-Leiro, MGMG; (...); Almenar-Bonet, L

Meeting Abstract. 2019

Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.

Crespo-Leiro MG; (...); Almenar-Bonet L

Article. 10.1111/ctr.13748. 2019

Use of Intra-aortic Balloon Pump as a Bridge to Heart Transplant in Spain: Results From the ASIS-TC Study.

Barge-Caballero, E; (...); Crespo-Leiro, MG

Article. 10.1016/j.rec.2018.07.003. 2019

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

Gonzalez-Vilchez F; (...); Blasco T

Article. 10.1016/j.ijcard.2013.11.036. 2014

Use of tolvaptan in patients with hyponatremia due to heart failure: initial experience.

Rodríguez-de Muñoz YM; (...); Salvador-Sanz A

Letter. 10.1016/j.rec.2012.09.010. 2013

Usefulness of biomarkers to predict prognosis after heart transplant

Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar

Article. 10.1016/j.rec.2024.04.019. 2024

Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary Experience.

Article. 10.1016/j.transproceed.2021.07.051. 2021

Usefulness of short-term peripheral ambulatory ultrafiltration in heart failure refractory to diuretics. Initial experience.

Guerrero Cervera B; (...); Almenar Bonet L

Article. 10.1016/j.medcli.2023.04.008. 2023

Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant

Ezzitouny, M.; (...); Marinez-Dolz, L.

Meeting Abstract. 2020

Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.07.058. 2021

Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry

Ortiz-Bautista, Carlos; (...); Delgado-Jimenez, Juan F.

Article. 10.1111/ctr.14774. 2022

Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.

Pastor Pueyo, Pablo; (...); Worner Diz, Fernando

Article. 10.1007/s00392-023-02225-0. 2023

Validation of miR-181A-5p as a biomarker of acute rejection after heart transplantation. Multicenter study

Crespo-Leiro, M.; (...); Domenech-Garcia, N.

Meeting Abstract. 2023

Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study.

Goirigolzarri Artaza, Josebe; (...); Segovia Cubero, Javier

Article. 10.1016/j.recesp.2020.01.033. 2020

Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Ezzitouny M; (...); Martínez-Dolz L

Article. 10.3390/jpm11111122. 2021

Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Variations in the medical treatment of heart failure during admission for decompensation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: results from a nationwide Spanish registry.

Barge-Caballero G; (...); Barge-Caballero E

Article. 10.1093/icvts/ivz155. 2019

Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study

Marques-Sule, Elena; (...); Luis Cabanillas-Garcia, Juan

Article. 10.3390/ijerph192215316. 2022

What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Bonet, Almenar

Meeting Abstract. 2024

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Donoso Trenado, V.; (...); Almenar-Bonet, L.

Meeting Abstract. 2024

What motivates heart transplantation patients to exercise and engage in physical activity? A network analysis.

Marques-Sule, Elena; (...); Machado, Felipe V C

Article. 10.1093/eurjcn/zvad051. 2023

Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study.